No serious adverse reactions recorded in synthetic 5-MeO-DMT study; California psychedelics bill advances; Are medical trainees ready for psychedelics?
DEA announces hearing on obscure hallucinogenic compounds; Petitioning the FDA for a public meeting on Lykos and MDMA; Psychedelic church sues for defamation
Tapering off antidepressants before psilocybin treatment; New concerns about MAPS’s MDMA trials; University of Maryland Baltimore joins patent lawsuit against Compass
Another Breakthrough Therapy Designation for a psychedelic drug from the FDA; A critique of the mixing of psychedelic science and spirituality at Johns Hopkins; The patient-therapist bond
MindMed receives FDA breakthrough therapy designation for LSD; Psychedelics figure Ben Sessa’s medical license suspended for one year; Serotonin toxicity after combining psilocybin and antidepressants